Cargando…

The Application and Analytical Pathway of Dexmedetomidine in Ischemia/Reperfusion Injury

Ischemia/reperfusion cerebral injury can cause serious damage to nerve cells. The injured organelles are cleared by autophagy eventually, which is critical for cell survival. Dexmedetomidine is neuroprotective in various ischemia/reperfusion models. Mitochondrial calcium uniporter (MCU) is the most...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Ying, Jia, Changxin, He, Jianshuai, Zhao, Yang, Chen, Huayong, Wang, Shilei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948278/ https://www.ncbi.nlm.nih.gov/pubmed/31949972 http://dx.doi.org/10.1155/2019/7158142

Ejemplares similares

Mechanisms of Dexmedetomidine in Neuropathic Pain
por: Zhao, Yang, et al.
Publicado: (2020)

Effect of dexmedetomidine on lung ischemia-reperfusion injury
por: JIANG, LILI, et al.
Publicado: (2014)

Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway
por: Yang, Ke, et al.
Publicado: (2023)

Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury
por: Lempiäinen, Juha, et al.
Publicado: (2014)

Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice
por: Gu, Jianteng, et al.
Publicado: (2011)

Evolving spectrum of dexmedetomidine preconditioning for Ischemia–reperfusion injury amelioration
por: Kohli, Jasvinder K., et al.
Publicado: (2020)

Dexmedetomidine Ameliorates Cardiac Ischemia/Reperfusion Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT3 Pathway
por: He, Hong, et al.
Publicado: (2023)

Effect of dexmedetomidine pretreatment on lung injury following intestinal ischemia-reperfusion
por: SHEN, JINMEI, et al.
Publicado: (2013)

Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats
por: Bao, Naren, et al.
Publicado: (2020)

Irisin Contributes to the Hepatoprotection of Dexmedetomidine during Intestinal Ischemia/Reperfusion
por: Fan, Xin, et al.
Publicado: (2019)

Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress
por: Li, Jinjie, et al.
Publicado: (2019)

The activation of SIRT3 by dexmedetomidine mitigates limb ischemia-reperfusion–induced lung injury
por: Wang, Lei, et al.
Publicado: (2022)

Amelioration of myocardial ischemia/reperfusion injury in diabetes: A narrative review of the mechanisms and clinical applications of dexmedetomidine
por: Sun, Meng, et al.
Publicado: (2022)

The preventive effects of dexmedetomidine against intestinal ischemia-reperfusion injury in Wistar rats
por: Zhang, Xue-kang, et al.
Publicado: (2015)

The effect of dexmedetomidine on gastric ischemia reperfusion injury in rats. Biochemical and histopathological evaluation
por: Kuyrukluyildiz, Ufuk, et al.
Publicado: (2021)

Dexmedetomidine pretreatment alleviates cerebral ischemia/reperfusion injury by inhibiting neuroinflammation through the JAK2/STAT3 pathway
por: Liu, Huan, et al.
Publicado: (2022)

Pretreatment with dexmedetomidine alleviates lung injury in a rat model of intestinal ischemia reperfusion
por: Chen, Yaping, et al.
Publicado: (2020)

Dexmedetomidine Pretreatment Protects Against Myocardial Ischemia/Reperfusion Injury by Activating STAT3 Signaling
por: Chen, Zhao-Rong, et al.
Publicado: (2023)

Use of dexmedetomidine to alleviate intestinal ischemia-reperfusion injury via intestinal microbiota modulation in mice
por: Dong, Ye-Hong, et al.
Publicado: (2022)

Effects of dexmedetomidine on renal microcirculation in ischemia/reperfusion-induced acute kidney injury in rats
por: Yang, Szu-Jen, et al.
Publicado: (2021)

Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury
por: CHENG, XIANG YANG, et al.
Publicado: (2016)

Dexmedetomidine Ameliorates Lung Injury Induced by Intestinal Ischemia/Reperfusion by Upregulating Cannabinoid Receptor 2, Followed by the Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway
por: Chen, Meng, et al.
Publicado: (2020)

Renoprotective effects of dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats
por: Kim, Seung Hyun, et al.
Publicado: (2018)

Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats
por: Hu, Bin, et al.
Publicado: (2023)

Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation
por: Si, Yanna, et al.
Publicado: (2013)

Administration of Dexmedetomidine Does Not Produce Long-Term Protective Effect on Testicular Damage Post Testicular Ischemia-Reperfusion Injury
por: Xiao, Jing, et al.
Publicado: (2021)

Protective Effects of Dexmedetomidine and Oxycodone in Patients Undergoing Limb Ischemia-Reperfusion
por: Cheng, Wenjie, et al.
Publicado: (2019)

Dexmedetomidine attenuates neuronal injury induced by cerebral ischemia-reperfusion by regulating miR-199a
por: Zhu, Yulin, et al.
Publicado: (2021)

Dexmedetomidine inhibits neuronal apoptosis by inducing Sigma-1 receptor signaling in cerebral ischemia-reperfusion injury
por: Zhai, Meili, et al.
Publicado: (2019)

Dexmedetomidine attenuates spinal cord ischemia–reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits
por: Sun, Zhixiang, et al.
Publicado: (2018)

Dexmedetomidine attenuates lung apoptosis induced by renal ischemia–reperfusion injury through α(2)AR/PI3K/Akt pathway
por: Li, Juanjuan, et al.
Publicado: (2018)

Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury
por: Zhang, Juan, et al.
Publicado: (2019)

Dexmedetomidine attenuates cerebral ischemia/reperfusion injury in neonatal rats by inhibiting TLR4 signaling
por: Cheng, Jiangxia, et al.
Publicado: (2018)

Does remifentanil attenuate renal ischemia–reperfusion injury better than dexmedetomidine in rat kidney?
por: Erkılıç, E, et al.
Publicado: (2017)

Dexmedetomidine preconditioning protects against lung injury induced by ischemia-reperfusion through inhibition of autophagy
por: Zhang, Wei, et al.
Publicado: (2017)

Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation
por: Huang, Yaru, et al.
Publicado: (2021)

Dexmedetomidine Alleviates Lung Oxidative Stress Injury Induced by Ischemia-Reperfusion in Diabetic Rats via the Nrf2-Sulfiredoxin1 Pathway
por: Wang, Xuan, et al.
Publicado: (2022)

Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis
por: Zhang, Xiong, et al.
Publicado: (2020)

Perioperative Dexmedetomidine attenuates brain ischemia reperfusion injury possibly via up-regulation of astrocyte Connexin 43
por: Zheng, Xiaoyang, et al.
Publicado: (2020)

Role of Keap1-Nrf2/ARE signal transduction pathway in protection of dexmedetomidine preconditioning against myocardial ischemia/reperfusion injury
por: Li, Hui-xian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3t5irlbjeg4i6cg8qds02r41q1